Elizabeth Cabraser and Robert Nelson Named “Top 100 Lawyers in California” for 2020

The Daily Journal (subscription) has named Lieff Cabraser attorneys Elizabeth J. Cabraser and Robert J. Nelson to its annual list of the Top 100 Lawyers in California. After reviewing hundreds of nominations, The Daily Journal honors a chosen 100 of California’s leading lawyers who are involved in “the most cutting-edge work in litigation, regulation, and corporate transactions, and who have had

2020-09-16T15:36:14+00:00September 16th, 2020|Awards, Firm News|

Benchmark Litigation Names Elizabeth Cabraser and Kelly Dermody “Top 250 Women in Litigation” for 2020

Benchmark Litigation has named Lieff Cabraser partners Elizabeth J. Cabraser and Kelly M. Dermody to its Top 250 Women in Litigation 2020 listing. Benchmark Litigation, touted as “the definitive guide to America’s leading litigation firms and attorneys,” covers the United States, Canada and Mexico – is now in its thirteenth year

2023-03-14T17:08:06+00:00August 19th, 2020|Awards, Firm News|

Elizabeth Cabraser in Trial Magazine on Meaningful Settlements that Bring Justice for Clients and Society

The American Association for Justice’s April 2020 issue of Trial magazine “Finding Your Way” includes a new article featuring commentary from Lieff Cabraser partner Elizabeth Cabraser, wherein she discusses meaningful settlements she’s been involved in and gives advice to lawyers on negotiating terms in settlements that bring justice for both clients

2022-08-10T17:24:13+00:00April 3rd, 2020|Commentary, Firm News|

Elizabeth Cabraser Talks To Law.com About How Plaintiffs’ Firms Are Functioning During COVID-19

Law.com has published a profile on the impact of the coronavirus outbreak on the way premier plaintiff law firms are conducting business in this week’s Critical Mass briefing for class action and mass tort attorneys. The profile features interviews with several prominent plaintiffs’ lawyers on working through isolation. The publication notes

2022-08-10T17:23:57+00:00April 1st, 2020|Firm News|

Seven Lieff Cabraser Attorneys Recognized as 2020 Lawdragon 500 Leading Lawyers

Lawdragon legal magazine has published its annual listing of the 500 “Leading Lawyers in America,” a list that includes Lieff Cabraser partners Elizabeth J. Cabraser, Kelly M. Dermody, Eric B. Fastiff, Steven E. Fineman, Wendy R. Fleishman, Annika K. Martin, and Robert J. Nelson. Lawdragon also selected Lieff Cabraser partner Richard

2022-08-10T17:23:33+00:00March 27th, 2020|Awards, Firm News|

Elizabeth Cabraser, Paulina do Amaral, and Annika K. Martin to Serve as Faculty in Upcoming March 2020 Duke University Mass Tort MDL Certificate Program

The Duke Law School Bolch Judicial Institute is holding its intensive 3-day mass-tort MDL instructional program beginning, Wednesday, March 11-13, 2020. Faculty will include two Duke Law professors, six experienced MDL judges, and 25 lawyers who have either served as preeminent mass-tort lead counsel or chaired specific-task MDL committees. The program is designed for both plaintiff and

2020-02-27T14:52:57+00:00February 27th, 2020|Firm News|

Elizabeth Cabraser, Paulina do Amaral, and Annika K. Martin to Serve as Faculty in March 2020 Duke University Mass Tort MDL Certificate Program

The Duke Law School Bolch Judicial Institute is holding an intensive 3-day mass-tort MDL instructional program from March 11-13, 2020. Faculty will include two Duke Law professors, six experienced MDL judges, and 25 lawyers who have either served as preeminent mass-tort lead counsel or chaired specific-task MDL committees. The program is designed for both plaintiff and defense

2020-01-10T12:56:56+00:00January 10th, 2020|Firm News|

Elizabeth Cabraser Talks with Law360 About National Opioids Case, Other Litigation, Career

Law360 (subscription) has published an in-depth interview with Lieff Cabraser partner Elizabeth J. Cabraser that includes a focus on the complexities of navigating the nationwide opioid litigation, which has pitted local communities against the prescription drug industry as those harmed seek redress over the destructive opioid addiction crisis.

2022-08-10T18:15:07+00:00December 7th, 2019|Firm News|

Title